- Home
- LUNG vs DSM Comparison
LUNG vs DSM Comparison
Compare LUNG & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- DSM
- Stock Information
- Founded
- LUNG 1995
- DSM 1989
- Country
- LUNG United States
- DSM United States
- Employees
- LUNG N/A
- DSM N/A
- Industry
- LUNG Industrial Specialties
- DSM Investment Managers
- Sector
- LUNG Health Care
- DSM Finance
- Exchange
- LUNG Nasdaq
- DSM Nasdaq
- Market Cap
- LUNG 124.0M
- DSM 275.8M
- IPO Year
- LUNG 2020
- DSM N/A
- Fundamental
- Price
- LUNG $2.78
- DSM $5.70
- Analyst Decision
- LUNG Buy
- DSM
- Analyst Count
- LUNG 6
- DSM 0
- Target Price
- LUNG $11.53
- DSM N/A
- AVG Volume (30 Days)
- LUNG 311.3K
- DSM 161.7K
- Earning Date
- LUNG 07-30-2025
- DSM 01-01-0001
- Dividend Yield
- LUNG N/A
- DSM 3.97%
- EPS Growth
- LUNG N/A
- DSM N/A
- EPS
- LUNG N/A
- DSM N/A
- Revenue
- LUNG $87,473,000.00
- DSM N/A
- Revenue This Year
- LUNG $18.02
- DSM N/A
- Revenue Next Year
- LUNG $18.17
- DSM N/A
- P/E Ratio
- LUNG N/A
- DSM N/A
- Revenue Growth
- LUNG 19.84
- DSM N/A
- 52 Week Low
- LUNG $2.50
- DSM $4.69
- 52 Week High
- LUNG $9.37
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- LUNG 41.83
- DSM 58.34
- Support Level
- LUNG $2.52
- DSM $5.55
- Resistance Level
- LUNG $2.84
- DSM $5.69
- Average True Range (ATR)
- LUNG 0.16
- DSM 0.04
- MACD
- LUNG 0.04
- DSM 0.02
- Stochastic Oscillator
- LUNG 46.36
- DSM 88.24
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.